Literature DB >> 28334343

PathwayMapper: a collaborative visual web editor for cancer pathways and genomic data.

Istemi Bahceci1, Ugur Dogrusoz1, Konnor C La2, Özgün Babur3, Jianjiong Gao4, Nikolaus Schultz4,5.   

Abstract

MOTIVATION: While existing network visualization tools enable the exploration of cancer genomics data, most biologists prefer simplified, curated pathway diagrams, such as those featured in many manuscripts from The Cancer Genome Atlas (TCGA). These pathway diagrams typically summarize how a pathway is altered in individual cancer types, including alteration frequencies for each gene.
RESULTS: To address this need, we developed the web-based tool PathwayMapper, which runs in most common web browsers. It can be used for viewing pre-curated cancer pathways, or as a graphical editor for creating new pathways, with the ability to overlay genomic alteration data from cBioPortal. In addition, a collaborative mode is available that allows scientists to co-operate interactively on constructing pathways, with support for concurrent modifications and built-in conflict resolution.
AVAILABILITY AND IMPLEMENTATION: The PathwayMapper tool is accessible at http://pathwaymapper.org and the code is available on Github ( https://github.com/iVis-at-Bilkent/pathway-mapper ). CONTACT: ivis@cs.bilkent.edu.tr. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author (2017). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Mesh:

Year:  2017        PMID: 28334343      PMCID: PMC5859976          DOI: 10.1093/bioinformatics/btx149

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  15 in total

1.  Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.

Authors:  Jianjiong Gao; Bülent Arman Aksoy; Ugur Dogrusoz; Gideon Dresdner; Benjamin Gross; S Onur Sumer; Yichao Sun; Anders Jacobsen; Rileen Sinha; Erik Larsson; Ethan Cerami; Chris Sander; Nikolaus Schultz
Journal:  Sci Signal       Date:  2013-04-02       Impact factor: 8.192

Review 2.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

3.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

Review 4.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

5.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

6.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

Review 7.  Tools for visualization and analysis of molecular networks, pathways, and -omics data.

Authors:  Jose M Villaveces; Prasanna Koti; Bianca H Habermann
Journal:  Adv Appl Bioinform Chem       Date:  2015-06-04

8.  Integrated genomic characterization of oesophageal carcinoma.

Authors: 
Journal:  Nature       Date:  2017-01-04       Impact factor: 49.962

9.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

10.  Comprehensive molecular profiling of lung adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

View more
  22 in total

1.  MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations.

Authors:  Sisheng Liu; Jinpeng Liu; Yanqi Xie; Tingting Zhai; Eugene W Hinderer; Arnold J Stromberg; Nathan L Vanderford; Jill M Kolesar; Hunter N B Moseley; Li Chen; Chunming Liu; Chi Wang
Journal:  Bioinformatics       Date:  2021-06-09       Impact factor: 6.937

Review 2.  Tumor Suppressive Effects of GAS5 in Cancer Cells.

Authors:  Jesminder Kaur; Nur'ain Salehen; Anwar Norazit; Amirah Abdul Rahman; Nor Azian Abdul Murad; Nik Mohd Afizan Nik Abd Rahman; Kamariah Ibrahim
Journal:  Noncoding RNA       Date:  2022-05-28

3.  Oncogenic Signaling Pathways in The Cancer Genome Atlas.

Authors:  Francisco Sanchez-Vega; Marco Mina; Joshua Armenia; Walid K Chatila; Augustin Luna; Konnor C La; Sofia Dimitriadoy; David L Liu; Havish S Kantheti; Sadegh Saghafinia; Debyani Chakravarty; Foysal Daian; Qingsong Gao; Matthew H Bailey; Wen-Wei Liang; Steven M Foltz; Ilya Shmulevich; Li Ding; Zachary Heins; Angelica Ochoa; Benjamin Gross; Jianjiong Gao; Hongxin Zhang; Ritika Kundra; Cyriac Kandoth; Istemi Bahceci; Leonard Dervishi; Ugur Dogrusoz; Wanding Zhou; Hui Shen; Peter W Laird; Gregory P Way; Casey S Greene; Han Liang; Yonghong Xiao; Chen Wang; Antonio Iavarone; Alice H Berger; Trever G Bivona; Alexander J Lazar; Gary D Hammer; Thomas Giordano; Lawrence N Kwong; Grant McArthur; Chenfei Huang; Aaron D Tward; Mitchell J Frederick; Frank McCormick; Matthew Meyerson; Eliezer M Van Allen; Andrew D Cherniack; Giovanni Ciriello; Chris Sander; Nikolaus Schultz
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

4.  RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.

Authors:  Douglas A Mata; Soo-Ryum Yang; Donna C Ferguson; Ying Liu; Rohit Sharma; Jamal K Benhamida; Hikmat A Al-Ahmadie; Debyani Chakravarty; David B Solit; Satish K Tickoo; Sounak Gupta; Maria E Arcila; Marc Ladanyi; Darren R Feldman; Victor E Reuter; Chad M Vanderbilt
Journal:  Urology       Date:  2020-07-25       Impact factor: 2.649

5.  Integrative network modeling reveals mechanisms underlying T cell exhaustion.

Authors:  Hamid Bolouri; Mary Young; Joshua Beilke; Rebecca Johnson; Brian Fox; Lu Huang; Cristina Costa Santini; Christopher Mark Hill; Anne-Renee van der Vuurst de Vries; Paul T Shannon; Andrew Dervan; Pallavur Sivakumar; Matthew Trotter; Douglas Bassett; Alexander Ratushny
Journal:  Sci Rep       Date:  2020-02-05       Impact factor: 4.379

6.  Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity.

Authors:  Xinhui Li; Jian Zhou; Mingming Xiao; Lingyu Zhao; Yan Zhao; Shuoshuo Wang; Shuangshu Gao; Yuan Zhuang; Yi Niu; Shijun Li; Xiaobo Li; Yuanyuan Zhu; Minghui Zhang; Jing Tang
Journal:  Front Cell Dev Biol       Date:  2021-07-01

7.  A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma.

Authors:  Victor McPherson; Brendan Reardon; Aravind Bhayankara; Sasinya N Scott; Mariel E Boyd; Ilana R Garcia-Grossman; Ashley M Regazzi; Asia S McCoy; Philip H Kim; Hikmat Al-Ahmadie; Irina Ostrovnaya; Andrew J Roth; Azeez Farooki; Michael F Berger; Jonathan E Rosenberg; David B Solit; Eliezer Van Allen; Matthew I Milowsky; Dean F Bajorin; Gopa Iyer
Journal:  Cancer       Date:  2020-08-07       Impact factor: 6.921

8.  The genomic landscape of Mongolian hepatocellular carcinoma.

Authors:  Julián Candia; Enkhjargal Bayarsaikhan; Mayank Tandon; Anuradha Budhu; Marshonna Forgues; Lkhagva-Ochir Tovuu; Undarmaa Tudev; Justin Lack; Ann Chao; Jigjidsuren Chinburen; Xin Wei Wang
Journal:  Nat Commun       Date:  2020-09-01       Impact factor: 14.919

9.  Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes.

Authors:  Musalula Sinkala; Nicola Mulder; Darren Patrick Martin
Journal:  Oncotarget       Date:  2018-06-26

Review 10.  A survey and evaluation of Web-based tools/databases for variant analysis of TCGA data.

Authors:  Zhuo Zhang; Hao Li; Shuai Jiang; Ruijiang Li; Wanying Li; Hebing Chen; Xiaochen Bo
Journal:  Brief Bioinform       Date:  2019-07-19       Impact factor: 11.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.